PRODUCTS
Product Name | Strength | Image (not to scale) | Pack Size | NDC # | RLD / Brand Name | TE Rating | Therapeutic Category |
---|---|---|---|---|---|---|---|
Varenicline Tartrate Tablets | 0.5mg |
53 |
70748-127-49 |
Chantix® |
AB |
Smoking Cessation Aids |
|
Turqoz™ | 0.3mg/0.03mg |
28 x 3 |
68180-895-13 |
Lo/Ovral-28® |
AB |
Oral Contraceptives |
|
Thiamine Hydrochloride Injection USP | 200mg/2ml (100mg/ml) |
25ml |
70748-347-02 |
Thiamine Hydrochloride Injection USP |
AP |
B1 Vitamins |
|
Sodium Sulfate, Potassium Sulfate and Magnesium Sulfate for oral solution. | 1.6g per 6 ounces |
177mL |
43386-700-83 |
Suprep® Bowel Prep Kit |
AA |
Osmotic Laxative |
|
Sildenafil for Oral Suspension | 10mg/mL |
112mL |
68180-283-01 |
Revatio® |
AB |
Phosphodiesterase-5 (PDE-5) Inhibitors |
|
Sevelamer Hydrochloride Tablets | 800mg |
180 |
70748-173-26 |
Renagel® |
AB |
Phosphate binders |
|
Rufinamide Tablets USP | 200mg |
120 |
68180-803-16 |
Banzel® |
AB |
Anticonvulsants |
|
Pentazocine and Naloxone Tablets USP | 50mg/0.5mg |
100 |
43386-680-01 |
Talwin® NX |
AB |
Adjunct to Anesthesia Opioid Analgesic |
|
Paliperidone Extended-Release Tablet | 1.5mg |
30 |
68180-526-06 |
Invega® |
AB |
Atypical antipsychotics |
|
Nitrofurantoin Macrocrystalline Capsules USP | 50mg |
100 |
43386-641-01 |
Macrodantin® |
AB |
Antibiotic |
|
Moxifloxacin Ophthalmic Solution USP | 0.5% |
3mL in a 5mL bottle |
68180-421-01 |
Moxeza® |
AT2 |
Anti-infective |
|
Mirabegron Extended-Release Tablets | 25mg |
30 |
68180-151-06 |
Myrbetriq® |
AB |
Beta-3 Adrenergic Agonist |
|
Merzee® (norethindrone acetate and ethinyl estradiol and ferrous fumarate capsules) | 1 mg/20 mcg |
28 |
43386-371-32 |
Taytulla® |
AB |
Oral Contraceptives |
|
Lurasidone Hydrochloride Tablets | 20mg |
30 |
68180-673-06 |
Latuda® |
AB |
Atypical antipsychotics |
|
Ibuprofen and Famotidine Tablets | 800mg/ 26.6mg |
90 |
70748-312-09 |
Duexis® |
AB |
NSaID |
|
Ganirelix Acetate Injection | 250mcg/0.5mL |
(1) 250mcg single-dose pre-filled syringe |
70748-274-01 |
Ganirelix Acetate Injection |
AP |
Competitive gonadotropin-releasing hormone antagonist (GnRH antagonist) |
|
Formoterol Fumarate Inhalation Solution | 20mcg/2mL |
30 UD Vials |
70748-261-30 |
Perforomist® |
AN |
Long-acting beta agonists (LABAs)/ Bronchodilator |
|
Fenofibrate Capsules | 90mg |
30 |
68180-746-06 |
Antara® |
AB |
Antihyperlipidemic |
|
Doxycycline Monohydrate Capsules USP | 50mg |
50 |
68180-650-01 |
Monodox® |
AB |
Anti-Infectives |
|
Doxycycline Capsules | 40mg |
30 |
70748-308-06 |
Oracea® |
AB |
Antibiotic |
|
Diclofenac Sodium Topical Solution | 2% |
112g |
68180-537-01 |
Pennsaid® 2% |
AB |
Topical nonsteroidal anti-inflammatory drug (NSAID) |
|
Diazepam Rectal Gel | 10 mg & 20 mg |
4.4 cm & 6.0 cm |
43386-281-01 |
||||
Desvenlafaxine Extended-Release Tablets | 25mg |
30 |
68180-592-06 |
Pristiq® |
AB |
Serotonin and Norepinephrine Reuptake Inhibitor (SNRI) |
|
Desoximetasone Topical Spray | 0.25% |
100 mL |
68180-944-33 |
Topicort® Topical Spray |
AT |
Corticosteroid |
*All registered trademarks are the property of their respective owners. These products are intended for U.S. residents only.